The L&G Pharma Breakthrough ETF

The L&G Pharma Breakthrough UCITS ETF is an Exchange Traded Fund that owns shares in pharmaceutical companies, that looks for Long-term value in the pharmaceutical sub-sector that benefits from certain commercial and regulatory incentives.

https://fundcentres.lgim.com/srp/documents-id/9c1df141-4b11-414b-a098-b5934daf6dce/Fact-sheet_LG-Pharma-Breakthrough-UCITS-ETF-Pharma-Breakthrough-USD-Acc.pdf

It’s top ten holdings are:-

Array BioPharma 6.6% of the fund

PTC Therapeutics 4.2% of the fund

PharmaMar 4.0% of the fund

Grifols 3.7% of the fund

CSL 3.6% of the fund

Nippon Shinyaku 3.6% of the fund

Celgene 3.6% of the fund

Jazz Pharmaceuticals 3.4% of the fund

Novartis 3.3% of the fund

Ipsen 3.3% of the fund

https://www.shareshop.hsbc.co.uk/shareshop/security.cgi?csi=54634586&action=

Leave a Reply

Your email address will not be published. Required fields are marked *